AMRUTANJAN vs GRANULES: Stock Comparison

Amrutanjan Health Care Limited vs Granules India Limited

Live data: 22 July 2026, 3:06 PM IST • Source: NSE and company filings

Granules India Limited is the larger company by market capitalisation. Amrutanjan Health Care Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Granules India Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Amrutanjan Health Care Limited and Granules India Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMRUTANJAN is more favourable on 7 of 11 scored metrics and GRANULES on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
GRANULES is the larger company
₹21,158 Cr vs ₹1,528 Cr
P/E Ratio
AMRUTANJAN has a lower P/E
26.9x vs 36.28x
P/B Ratio
AMRUTANJAN has a lower P/B
4.21x vs 4.24x
EPS
GRANULES has higher earnings per share
₹24.44 vs ₹20.01
Dividend Yield
AMRUTANJAN has a higher dividend yield
1.02% vs 0.2%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 10.5%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 6.7%
ROE
AMRUTANJAN has a higher ROE
20% vs 13.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMRUTANJANGRANULES
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAMRUTANJANGRANULES
Live Price₹530₹852.9
Day Change-1.6%-2.6%
Volume21,75414.57 L
52-Week High₹790.95₹910
52-Week Low₹486₹432.6
Distance from 52W High-32.99%-6.27%

Valuation

MetricAMRUTANJANGRANULES
Market Cap₹1,528 Cr₹21,158 Cr
P/E Ratio26.9x36.28x
P/B Ratio4.21x4.24x
EPS₹20.01₹24.44
Book Value₹128.04₹205.21
Dividend Yield1.02%0.2%

Growth

MetricAMRUTANJANGRANULES
Revenue Growth (TTM YoY)10.5%22.8%
EPS Growth (TTM YoY)6.7%31.3%
Qtr Sales Growth22.8%
Qtr Profit Growth44.6%

Profitability & Leverage

MetricAMRUTANJANGRANULES
ROE20%13.7%
ROCE31.4%15.5%
Net Margin11.52%11.15%
Operating Margin17.7%22.1%
Debt to Equity0.02x0.3x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMRUTANJANGRANULES
Promoter Holding46.52%37.67%
FII Holding2.44% 0.27 pp17.5% 2.19 pp
DII Holding12.28% 0.38 pp16.11% 0.9 pp
Public Holding38.72% 0.11 pp28.38% 1.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Amrutanjan Health Care Limited and Granules India Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.